The hepatitis C virus (HCV) core protein is considered to influence multiple cellular processes. We developed a human hepatoblastoma HepG2-derived inducible cell line, Hep191, which allows tightly regulated expression of the core protein at relatively low but physiological levels under control of the ecdysone-regulated promoter. By transcriptional profiling, we identified differentially expressed genes, some of which are involved in cell growth or apoptosis such as inhibitor of caspase-activated DNase (ICAD), defender against cell death 1, tumor necrosis factor (TNF) receptor 1, and cytochrome c oxidase subunit VIII. Furthermore, we found that core protein expression increases a steady-state level of ICAD protein, possibly through enhancing its promoter activity, and inhibits caspase-3 activity induced by anti-Fas antibody. Since Fas-or TNF-mediated DNA fragmentation is suppressed in the core-induced Hep191 cells, these findings suggest that expression of HCV core at physiological levels confers blocking activity of caspase-activated DNase and consequently inhibiting apoptotic cell death.
Introduction
A main characteristic feature of hepatitis C virus (HCV) infection is its persistent nature, which often leads to chronic hepatitis and liver cirrhosis. HCV infection is also strongly associated with the development of hepatocellular carcinoma (HCC) Kuo et al., 1989; Saito et al., 1990) . Another characteristic is its highly specific host range for replication. To understand the exact mechanism of pathogenesis and persistence of HCV infection, it is important to elucidate virus-cell interaction, particularly in hepatic cells. We have been interested in the role of HCV core protein, which constitutes not only viral nucleocapsids but has multifunctions for pathogenesis or establishment of persistent infection of HCV (Lai and Ware, 1999; Thomson and Liang, 2000; Suzuki et al., 1999) .
Apoptosis is definitely one of the key factors associated with liver injury and chronicity of HCV infection (Hayashi and Mita, 1997; Lau et al., 1998; Patel et al., 1998) . However, its molecular mechanism is not clear yet. Apoptosis mediated by Fas or tumor necrosis factor (TNF) is a major pathway involved in a wide range of liver diseases. When Fas is constitutively expressed in hepatocytes and when agonistic anti-Fas antibodies are injected, the animals develop fatal fulminant hepatitis (Ogasawara et al., 1993; Lacronique et al., 1996) . On the other hand, several HCV proteins have been reported to modulate apoptosis induced by diverse stimuli in different experimental systems (Ray et al., 1996 (Ray et al., , 1998 Fujita et al., 1996; Ruggieri et al., 1997; Zhu et al., 1998 Zhu et al., , 2001 Marusawa et al., 1999; Dumoulin et al., 1999; Gale et al., 1999; Hahn et al., 2000; Tai et al., 2000; Honda et al., 2000; Otsuka et al., 2002) . However, the data shown to date, particularly with regards to the effects of the core protein, are not consistent. Several studies showed that the viral protein sensitizes apoptosis mediated by Fas, TNF-␣, or other signaling pathways, whereas other studies showed inhibition of such apoptosis. Difficulty in unraveling of functions of HCV proteins on pathogenesis might be due to, at least in part, the fact that many previous investigations were based on transient or stable expression systems using unrelevantly high expression systems. In these systems, only certain populations of cells expressing viral proteins at high levels were selected. Such settings may be different from those of chronic infection, where only low production of viral proteins is observed.
In the current study, we overcame this problem through the use of the ecdysone-based inducible system, in which expression of HCV core protein can be induced at physiological levels in the same cellular background. The combination of transcriptional profiling with functional studies demonstrated the alteration of expression of several cellular genes including those related to apoptosis. It is of interest to note that expression of the core protein increased a steadystate protein level of inhibitor of caspase-activated DNase (ICAD), possibly through enhancing its promoter activity, and inhibited caspase-3 activity induced by anti-Fas antibody. In addition, induced expression of HCV core protein inhibited Fas-and TNF-mediated DNA fragmentation. These findings suggest that up-regulation of ICAD and inhibition of caspase-3 activity by the core protein collaboratively play roles in inhibiting apoptotic cell death through blocking activity of caspase-activated DNase (CAD).
Results

Establishment of a cell line allowing the tightly regulated expression of HCV core protein
The ecdysone-inducible system was used to generate tightly regulated cell lines expressing HCV core protein. This system is based on the binding of the steroid hormone ecdysone analog such as ponasterone A (PNA) to a heterodimeric receptor comprising a modified ecdysone receptor (VgEcR) and retinoid X receptor (RXR). The binding subsequently activates the ecdysone-responsive promoter to express the target genes . After keeping the transfected culture for 3 weeks in the presence of Hygromycin and Zeocin, 27 Zeocin-Hygromycin-resistant clones were isolated. They were then screened for regulated HCV core expression by sensitive fluorescence enzyme immunoassay (FEIA) and Western blot analysis. Being induced by treatment with PNA (0.3-30 M) for 36 h, three of these clones (designated as Hep191) showed tightly regulated expression of the core protein. Western blot analysis of Hep191, clone 3 showed induction of 21-kDa HCV core protein in the presence of 30 M PNA. It was not detected in the absence of PNA (Fig. 1A) . FEIA analysis revealed that HCV core protein was observed as early as 3 h after addition of PNA and increased consistently up to 24 h. Continuous treatment with PNA showed that intracellular level of the core protein achieved after 24-h treatment was maintained during the whole culture period. Induced expression of the core protein was confirmed by indirect immunofluorescence staining (Fig. 1B) . HCV core protein induced by treatment with 30 M PNA for 48 h was localized exclusively within the cytoplasm. It seems that the core protein was essentially expressed uniformly in the induced Hep191 cells. No immunoreactivity was observed when the cells were cultured in the absence of PNA (data not shown).
We then examined "turning off" the regulation. Transcription intermediates of HCV core gene were monitored by reverse transcription-polymerase chain reaction (RT-PCR) in the cells in which the PNA medium was replaced by the vehicle-containing medium (Fig. 1C) . No HCV cDNA transcript was detectable after 24 h of PNA removal. Correspondingly, HCV core protein level decreased and it was not observed after 24 h of withdrawal by Western blotting (data not shown). Further quantitative analysis by FEIA indicated that PNA's HCV core protein induction is in a concentration-dependent manner with the range of 0.3-30 M of PNA for 36 h (Fig. 1D) . No detectable level of HCV core protein was observed in the cells not treated with PNA, indicating negligible background of expression in the uninduced states. Notably, this core protein level in Hep191 is comparable to those in the livers of hepatitis C patients (6 -1000 pg/mg total protein) and the transgenic mice developing hepatic steatosis and HCC (13-804 pg/mg total protein) (Koike et al., 2002; Tsutsumi et al., 2003) .
Previous studies examining functional properties of HCV proteins have been performed mainly in cells overproducing the viral proteins. Moreover, many of them were nonhuman liver cells or human nonliver cells. Our human liver cell derived Hep191 cells allow the tightly regulated expression of core protein at a physiological level. This will provide a unique system to investigate possible roles of core protein in viral pathogenesis. In most of the following experiments, Hep191, clone 3 was used and core protein expression was induced by adding 10 M PNA. Under this condition, the core protein level in the cells was approximately 500 to 1000 pg/mg total protein, which was little detected by Western blotting. We obtained similar results with the other two clones 21 and 37. These three clones have been maintained in culture for over 20 months and more than 90 passages without loss of tightly regulated gene expression.
Cell growth properties
To test the effects of induced expression of HCV core protein on cell growth, Hep191 cells were cultured in daily changed medium with or without PNA. The number of viable cells was determined by counting daily for 10 days. As shown in Fig. 2A , no differences were noted between growth curves of Hep191 cultured in the medium with 10% fetal bovine serum (FBS) in the presence and absence of PNA. Furthermore, the same saturation density was reached under both conditions. The result demonstrates that HCV core protein expressed in Hep191 cells has no influence on growth capacity, which is consistent with that in previous studies using human hepatoma Huh-7 cells (Li et al., 2002) and human osteosarcoma U-2OS cells (Moradpour et al., 1996) with tetracycline-inducible systems. Analogous results were found in slower growing Hep191 cells cultured in 1% FBS-containing medium (Fig. 2B) , suggesting that core expression does not confer serum independence to the cells. We also observed that the inducing agent, PNA, exerted no pleiotropic effects, confirming the advantage of using ecdysteroids, which are known not to affect physiology of mammalian cells.
Changes in gene expression in the core-induced Hep191 cells
We then compared the gene expression patterns in Hep191 cells in the presence and absence of 10 M PNA. A cDNA microarray consisting of 2304 human genes was used. cDNA labeling reactions were carried out in duplicate where the fluorescent dyes, Cy3 and Cy5, were switched during the synthesis, followed by hybridizing each probe pair to a separate microarray. A list of the genes demonstrating greater than two-fold change in average of two experiments is provided in Table 1 . We observed 12 genes up-regulated and 8 genes down-regulated upon induction of the core protein. Most of the genes differentially expressed were regulators of either transcription, RNA/protein metabolism, apoptosis, or signaling molecules. Among these, four genes which are involved in apoptosis regulation are noteworthy: the expression of (i) ICAD and (ii) defender against cell death 1 (DAD1) was increased, whereas the expression of (iii) TNF receptor 1 (TNFR1) and (iv) cytochrome c oxidase subunit VIII was decreased in the core-induced Hep191 cells.
To validate the differential expression of these genes, we performed semiquantitative RT-PCR analysis. For each assay, the reaction conditions and cycle numbers of PCR were individually optimized and adjusted so that the reaction fell within the linear range of product amplification. Glyceraldehyde-3-phosphatase dehydrogenase (GAPDH), whose expression was not altered, was used as a control for loading. Our RT-PCR qualitatively agreed with the expression patterns generated by microarray data (Fig. 3A) . PNA itself had no effect, or little if any, on these gene expressions in control HepRXR cells, which are not expressing the core protein. In addition to analyzing clone 3 of Hep191, semiquantitative RT-PCR was also performed with ICAD and GAPDH genes of clone 37 (Fig. 3B) . In good agreement with that observed with clone 3, expression of ICAD gene was up-regulated after induced expression of the core protein in clone 37.
Expression of the core protein resulted in activation of the ICAD promoter
We next focused on the impact of the core protein on ICAD expression. ICAD is a 45-kDa inhibitor of CAD, caspase-activated DNase, of 40-kDa (Liu et al., 1997; Enari et al., 1998) . ICAD exists as a complex with CAD in Note. Genes with two-fold or more increase (top) or decrease (bottom) in average of two experiments are indicated. proliferating cells. Upon apoptotic stimuli, caspases, particularly caspase-3, proteolytically process ICAD to release CAD from the complex, allowing CAD to catalyze the fragmentation of chromosomal DNA. As shown in Fig. 4A , we found a significant increase in ICAD protein in Hep191 cells treated with 10 M PNA for 48 h by Western blotting, whereas no change was observed in the control cells with the same treatment.
To address the molecular mechanism of up-regulation of ICAD expression by core protein, we examined whether the core expression is linked to ICAD promoter activity. ICAD promoter/luciferase reporter constructs used in this study are generous gifts from Dr. S. Nagata (Kawane et al., 1999) . However, HepG2-based Hep191 cells have low transfection efficiency, and these cells were not suitable for cotransfection experiments of control and experimental reporter vectors. We therefore adopted the 293T transient transfection system, in which transfection efficiency of each plasmid exhibits constantly about 80%. As shown in Fig. 4B , luciferase activity expressed from ICAD reporter construct, which includes the 110-bp 5Ј flanking region of the ICAD gene (pIPT-2), increased twofold following expression of the core protein. On the other hand, the 39-bp deletion at 5Ј region of the promoter (pIPT-3) resulted in a marked decrease with the core expression. The 39-bp region thus plays a role in regulating ICAD promoter activity by HCV core protein. Further 24-bp deletion (pIPT-4) caused threefold reduction of the activity in cells in both the presence and the absence of the core protein. The ICAD gene used in this reporter assay was murine in origin, but its 110-bp promoter region has 75% sequence identity to that in human ICAD gene. Furthermore, the putative binding sites for transcription factors, such as USF1 and GATA-1 in the 39-bp region, are well conserved between murine and human ICAD genes. Thus, these data indicate that stimulation of ICAD promoter activity by the core protein results in an elevated level of ICAD protein in the core-expressing cells.
Effects of HCV core protein expression on Fas-and TNF-␣-mediated DNA fragmentation in Hep191 cells
The above observation showing changes in expression of several apoptosis-related genes prompted us to study the role of HCV core protein in Fas-or TNF-␣-mediated apoptosis pathway. Hep191 cells with or without core induction were treated with anti-Fas antibody for 14 h. DNA ladders due to activation of nuclear endonucleases were then measured by quantitating cytoplasmic mono-and oligonucleosomes. As indicated in Fig. 5A , Hep191 cells treated with 10 M PNA showed decreased sensitivity against anti-Fasinduced DNA fragmentation. DNA-associated mono-and oligonucleosomes released into cytoplasm were reduced to 28% in the core-expressing Hep191 cells. To exclude the direct effects of PNA in apoptotic response, we examined the Fas-induced DNA fragmentation also in the control HepRXR cells. No difference in apoptotic response was observed in HepRXR cells in either the presence or the absence of PNA (Fig. 5A ). Prolonged induction of the core protein expression for 15 or 30 days with 10 M PNA also inhibited the Fas-and TNF-␣-mediated apoptosis (Fig. 5B) .
We further investigated the relation of induced HCV core protein and Fas-mediated apoptotic response. As shown by the terminal deoxynucleotidyltransferase-mediated dUTP nick end-labeling (TUNEL) technique in Fig. 6 , anti-Fas-treated Hep191 cells in the absence of PNA underwent apoptosis. Apoptotic cells showing DNA strand breaks were clearly demonstrated by in situ labeling. In contrast, the cells expressing HCV core protein exhibited little detectable fluorescence.
We further examined whether the induction of HCV core protein would inhibit the anti-Fas-stimulated caspase-3 activity. Treatment of the core-induced Hep191 cells with anti-Fas resulted in a decrease in the caspase-3 (or DEVDase) activity in these cell lysates (Fig. 7A) . Addition of PNA may not affect the enzyme activity per se, because no caspase-3 activity change was observed in HepRXR cells in the presence of 10 M PNA. However, it is known that the treatment with anti-Fas antibody triggers the cleavage of the inactive proform of caspase-3 by an upstream caspase to generate its active subunits (Dubrez et al., 1996) . Thus, we analyzed the level of 32-kDa procaspase-3, which decreases upon enzyme activation, by Western blotting (Fig. 7B ). As expected, Hep191 cells without PNA treatment demonstrated a decrease in the amount of the procaspase-3 in response to anti-Fas antibody. By contrast, the level of procaspase-3 in the cells treated with 10 M PNA was comparable to that under no apoptotic stimuli. We observed similar results in the other Hep191 clone, 37 (Fig. 7C) , confirming that activation of caspase-3 following treatment with anti-Fas antibody was inhibited by induced expression of the core protein. Since caspase-3 locates almost at the end of the apoptotic cascade, its inhibition strongly indicates that induced expression of the HCV core protein at moderate levels inhibits Fas-mediated DNA fragmentation in human liver cells.
Discussion
Deregulation of apoptosis or programmed cell death is involved in a wide range of pathological processes, including autoimmune hepatitis, fulminant hepatitis, and HCC. Although there is increasing evidence that the HCV core protein interacts with regulatory pathways controlling apoptosis, the role of this protein remains controversial because of the conflicting results in the literature, that is, its opposite effects in either inhibition or potentiation of apoptosis. It is likely that the expression level of the core protein, availability of apoptotic versus survival factors, and experimental setting might affect the fate of cells exposed to diverse stimuli.
In the current study, we have introduced the ecdysoneinducible expression system to establish a human hepatoblastoma HepG2-based stable cell line, Hep191, allowing tightly regulated expression of HCV core protein. In this system, no background expression is observed in the absence of the inducer. It is also possible to precisely control the expression levels in response to varying inducer concentrations. These are the advantages of using the ecdysonebased system over other inducible systems, such as the tetracycline-based system. Indeed, the ecdysone-inducible system was developed to address a main flaw of the tetracycline-inducible system, a relatively high background of expression in the uninduced state . In contrast to tetracycline, the lipophilic nature of the ecdysteroids such as PNA allows their efficient penetrance into cells and appropriate pharmacokinetics that prevent storage and expedite clearance, leading to a delicate temporal control of gene expression. Further, we observed no pleiotropic effects of the inducing agent. Neither cytotoxicity nor influence on cell proliferation was observed in PNA-treated cells (Fig. 2) . The lack of baseline cross-talk between the inducible system and endogenous cellular pathway is essential to study HCV-liver cell interaction. It is also noteworthy that the expression levels of HCV core protein in Hep191 cells can be controlled to the level comparable to those in the livers of hepatitis C patients and the HCV core-transgenic mice developing hepatic steatosis and HCC (Koike et al., 2002; Tsutsumi et al., 2003) . In this regard, most of the previous studies on possible roles of HCV core protein in viral pathogenesis depended on overexpression systems of either constitutively expressing cell lines or transiently transfected cells. Thus, Hep191 cells based on the ecdyson system may be useful as a model of HCV core-host cell interaction closer to the virus infection setting than previous expression systems. Liver cell specific interaction included in this system would be important.
We applied this Hep191 cell line to analyze the gene expression profiling by using cDNA microarray technique. Clone-to-clone variability of cells can be controlled in this inducible system. Taking this advantage, we investigated the response of the same cells to two different stimuli. We identified 20 genes (0.9% of 2304 transcripts examined) which showed twofold or more difference between with and without the core induction. Among them were several genes related to transcriptional regulation, signaling, RNA/protein metabolism, and apoptosis. We subsequently performed semiquantitative RT-PCR of four apoptosis-related genes and confirmed that ICAD and DAD1 were up-regulated, and TNFR1 and cytochrome c oxidase subunit VIII were downregulated in the core-expressing cells. With regard to ICAD, its promoter activity was upregulated by the core protein expression and steady-state level of ICAD protein was subsequently increased. ICAD, otherwise known as DFF45 (DNA fragmentation factor 45-kDa subunit), is a caspase-3 substrate which is cleaved before apoptotic DNA fragmentation proceeds. Moreover, ICAD is a specific inhibitor of CAD, also called DFF40 (DNA fragmentation factor 40-kDa subunit), and is a molecular chaperone which is involved in proper folding of the endonuclease (reviewed by Nagata, 2000) . It has been reported that overexpression of ICAD inhibits staurosporineor Fas-induced DNA fragmentation . To our knowledge, the data presented here are the first to demonstrate increased expression of ICAD mediated by a viral protein through enhancing its promoter activity. In this study, we observed that in the core-expressing Hep191 cells expression of CAD did not change, as determined by Western blotting as well as cDNA microarray (data not shown). The maintenance of a 1:1 ratio of ICAD and CAD might be important for the homeostasis of normal cells, because an excess of ICAD will increase the threshold for downstream apoptotic signaling. Thus, our findings suggest that upregulation of ICAD by HCV core protein may contribute to metabolic perturbation such as inhibition of apoptosis in HCV-infected hepatocytes.
The DAD1 gene, identified as a defender against apoptotic death gene, was also up-regulated. The DAD1 gene encodes a subunit of the oligosaccharyltransferase enzyme complex that initiates N-linked glycosylation (Nakashima et al., 1993) . This protein plays a role in inhibition of apoptosis in some cultured cells (Yoshimi et al., 2000) . Studies with mice carrying a null allele for DAD1 showed that this gene is required for proper processing of N-linked glycoproteins and for certain cell survival (Hong et al., 2000) . It is also of interest that DAD1 gene is highly expressed in HCC cells compared to adjacent nontumorous liver tissues through differential display analysis (Tanaka et al., 2001) .
TNFR1 is one of death receptors and relays death signals through a cytoplasmic sequence motif called the death domain. Upon TNF engagement, TNFR1 binds other death domain-containing proteins and subsequently leads to activation of caspases, resulting in apoptosis (for review, see Ashkenazi and Dixit, 1998) . Down-regulation of TNFR1 in our study is not consistent with the previous report showing HCV core protein binds to the cytoplasmic domain of TNFR1 and enhances TNF-induced apoptosis of certain mouse and human cells. In these cells, the presence of core protein did not alter the expression of TNFR1 (Zhu et al., 1998 (Zhu et al., , 2001 . The difference in the conditions of either cell culture or core expression may be attributed to this discrepancy.
Cytochrome c oxidase is the terminal enzyme complex in the mitochondrial respiratory chain, and cytochrome c oxidase subunit VIII is one of the 13 subunits of the complex. A progressive reduction in respiratory activity of cytochrome c oxidase induces cytochrome c release in anti-Fastriggered apoptotic cells (Hajek et al., 2001) . The release from the mitochondrial intermembrane space into the cytosol involves the activation of the apoptotic protease cascade together with Apaf-1 and procaspase-9 (Li et al., 1997) . Interestingly, cytochrome c release from mitochondria is inhibited in the liver of HCV protein-expressing transgenic mice, in which Fas-mediated apoptotic cell death was suppressed (Machida et al., 2001) . Nevertheless, the underlying mechanism of cytochrome c release is not well known yet. Further studies on down-regulation of cytochrome c oxidase subunit VIII in relation to respiratory activity of cytochrome c oxidase and cytochrome c release in our experimental setting are necessary.
We characterized the effect of HCV core protein on the cytokine-mediated apoptotic pathway in Hep191 cells. The cytokines Fas ligand and TNF-␣ are the critical components necessary for triggering receptor-mediated cell death in vivo. We show here that the core protein confers resistance against apoptotic DNA fragmentation induced by either anti-Fas antibody or TNF-␣ (Figs. 5 and 6 ). Our data confirmed that the pleiotropic effects of PNA do not cause this phenomenon, since we found no influence on the Fas-mediated apoptosis in control HepRXR cells even with a high concentration of PNA (30 M). To avoid clonal diversity during the selection of permanent transfectants, we also analyzed HepG2 cells transiently transfected with both core-expressing pIND191 and pVgRXR. We observed similar results of antiapoptotic response (data not shown).
Caspase-3 is recognized as an important effector molecule in the apoptotic pathway, and its activity arises following the cleavage of inactive proenzyme (procaspase-3) after Fas or TNFR is stimulated. We show here that expression of core protein inhibits caspase-3 activity induced by anti-Fas. It was shown by quantifying the enzyme activity in cell extracts and monitoring the level of inactive 32-kDa procaspase-3. Previously some reports indicated that HCV proteins, particularly core protein, are involved in augmentation of caspase activation induced by anti-Fas or TNF-␣ (Ruggieri et al., 1997; Hahn et al., 2000) , whereas others indicated its suppression (Marusawa et al., 1999; Otsuka et al., 2002; Machida et al., 2001 ). Since different experimental systems were used in these studies, the observed inconsistency may be due to the possible involvement of cellular factor(s) in certain cells. Alternatively, the expression level of the core protein may be different. A previous report from our laboratory demonstrated that the core protein sensitizes Fas-mediated apoptosis possibly accompanied by up-regulation of caspase-3 (Ruggieri et al., 1997) . We used Hep39 cells in that study. Hep39 cells are also originated from HepG2 cells and constitutively expresses the HCV core protein. Subsequently, we compared the steady-state level of the core protein in Hep39 and in Hep191 cells established in this study. The level in Hep39 cells is 100-to 500-fold higher than in Hep191 cells treated with 10 M PNA determined by FEIA (data not shown).
It is generally accepted that caspase-3 is the primary inactivator of ICAD and is mainly involved in proteolytic pathways that induce apoptotic internucleosomal DNA fragmentation (Wolf et al., 1999) . The results in the present study suggest that up-regulation of ICAD and inhibition of caspase-3 activity induced by the core protein collaboratively play roles in blocking DNase activity of CAD and consequently in inhibiting DNA fragmentation in human liver cells, which express the viral protein at moderate levels comparable to that found in patients with chronic liver diseases.
In conclusion, we established a tightly regulated inducible expression system of HCV core protein in human liver cells, where expression of the viral protein is promptly induced to physiological levels. Transcriptional profiling, coupled with studies to confirm gene expression, in this system allowed us to identify several interesting genes that may be involved in cell growth or apoptosis. Evidence that the core protein modulates ICAD expression and the pathway of caspase-3 activation should contribute to the understanding of the molecular mechanisms of HCV persistence and chronic liver diseases. Functional studies in the future to evaluate the significance of potential core-regulated genes implicating not only in apoptosis but in other cellular processes may also provide new directions for the detailed investigation of HCV pathogenesis.
Materials and methods
Construction of inducible expression vector for HCV core protein
HCV cDNA (nt 342 to 914), coding for the entire core protein (aa 1 to 191), was excised from the BglII site of the pCAGC191 (Suzuki et al., 2001 ) and inserted, using standard cloning procedures (Sambrook et al., 1989) , into the BamHI site of the inducible expression vector pIND/Hygro (Invitrogen, Carlsbad, CA) to yield plasmid pIND191. This vector contains five ecdysone/glucocorticoid response elements which allow binding of the modified VgEcR for activation of gene transcription and inducible expression of HCV core protein gene under control of a Drosophila minimal heat shock promoter. Hygromycin resistance gene in the vector allows selection of stable transfectant in mammalian cells.
Establishment of an inducible cell line
Stock cultures of human hepatoblastoma HepG2 cells were maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% FBS, 100 units/ml of penicillin, and 100 mg/ml of streptomycin and kept at 37°C in a 5% CO 2 incubator. To generate a stable cell line allowing tightly regulated expression of HCV core protein, HepG2 cells were cotransfected with both plasmid pIND191 and pVgRXR (Invitrogen). The latter vector that contains the gene conferring Zeocin resistance also encodes modified ecdysone receptor (VgEcR) and the retinoid X receptor. This vector thus provides an ecdysone functional heterodimeric receptor for activation of gene expression upon binding to an ecdysone analog, such as PNA (Invitrogen) .
Monolayers of HepG2 cells were transfected with the plasmids in the presence of Trans-lT LT1 (Mirus Corp. WI) according to the manufacturer's instructions. After transfection, transformants were selected in DMEM containing 500 g/ml of Hygromycin (Roche Diagnostics, Basel, Switzerland) and 400 g/ml of Zeocin (Invitrogen) for 3 to 5 weeks. Individual colonies were isolated and amplified, followed by screening inducible expression of HCV core protein. After 24 h of incubating the amplified clones in the medium with PNA at 10 M, expression of the core protein was determined by a sensitive FEIA (Kashiwakuma et al., 1996) (see below). Stable cell lines, which allow tightly regulated expression of the core protein, were designated as Hep191.
To obtain a control cell line not expressing HCV core protein, HepG2 cells were transfected with the plasmid pVgRXR. After transfection, transformants were selected in DMEM medium containing 400 g/ml of Zeocin. The isolated resistant colonies were designated as HepRXR.
Quantitation of HCV core protein
Hep 191 cells were induced to express HCV core protein using PNA at various concentrations ranging from 0.3 to 30 M for indicated periods. Expressed core protein was quantitated by FEIA method as reported previously (Kashiwakuma et al., 1996) . Briefly, cells were homogenized in a solution containing 0.3% Triton X-100, 1.5% (3-cholamidopropyl dimethylammonio) propanesulfonic acid, and 15% sodium dodecyl sulfate (SDS). After incubating at 56°C for 30 min, the samples were centrifuged at 1000 rpm for 5 min, and the supernatants were subjected to FEIA. Total protein concentration of the lysates was determined using the Pierce Micro BCA protein Assay Reagent Kit according to the manufacturer's instructions (Pierce, Rockford, IL).
Western blot analysis
Cells were washed with phosphate-buffered saline (PBS) and lysed in SDS sample buffer. Cell lysates were separated by 15 or 12.5% SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and electrotransferred to polyvinylidene difluoride membrane (Immobilion; Millipore Ltd., Bredford, MA). After blocking in nonfat milk solution (Block Ace, Yukijirushi Co., Sapporo, Japan), the membranes were probed with the monoclonal antibody against HCV core protein (B2, ANOGEN, Missisauga, Canada), as a primary antibody diluted 1:200 and incubated for 1 h at 37°C. After being washed, the membranes were incubated with horseradish peroxidase conjugated sheep anti-mouse or anti-rabbit immunoglobulins as secondary antibodies. Antigenantibody complexes were visualized by enhanced chemiluminescence detection system (ECL; Amersham Biosciences, Piscataway, NJ) according to the manufacturer's protocol.
Immunofluorescence microscopy
For indirect immunofluorescence staining of HCV core protein, Hep191 cells were grown in a tissue chamber slide in the presence of 30 M PNA for 48 h and fixed with 4% paraformaldehyde, followed by permeabilizing with 0.2% Triton X-100. After blocking in nonfat milk solution (Block Ace), cells were incubated for 1 h with the anticore monoclonal antibody. Following washing, cells were incubated for 1 h with Biotin-conjugated antibody to mouse immunoglobulin (Sigma-Aldrich, St. Louis, MO). To increase sensitivity and specificity of the antigen detection, ExtrAvidin conjugated with FITC (Sigma-Aldrich) was then added and incubated for 1 h, followed by examining with a fluorescent microscopy.
Cell growth property
To test cell growth of Hep191, 6 ϫ 10 4 cells per well were seeded into six-well tissue culture plates. Cells were cultured in DMEM with FBS 10 or 1% and the medium with and without 10 M PNA was changed daily. Cells from triplicate wells were harvested and viable cells were counted every other day for 10 days by trypan blue dye exclusion.
RT-PCR
Total RNAs were extracted from Hep191 and HepRXR cells using SV Total RNA Isolation System (Promega, Madison, WI) according to the manufacturers' protocols. Three micrograms of total RNAs was reverse transcribed by Superscript II (Invitrogen) using oligo(dT) primer. Amplification procedure using specific PCR primers was as follows: after 3 min at 96°C, the reaction of 96°C for 30 s, 55°C for 30 s, 72°C for 1 min was repeated for 20 -30 cycles, and finally 10 min at 72°C for one cycle. A minimum amount of PCR cycle was carried out to stay within the linear amplification process for each gene. PCR products were electrophoresed on 2.0% agarose/ethidium bromide gels.
Microarray analysis
Preparation procedure of cDNA microarray was described previously (Yoshikawa et al., 2000; Otsuka et al., 2001) . Total RNAs from Hep191 in the presence or absence of PNA at 10 M for 36 h were isolated with ISOGEN Reagent (Nippon Gene, Tokyo, Japan). Poly(A)
ϩ RNAs were obtained with Oligotex-dT 30 mRNA purification kit (TaKaRa Bio. Inc., Kyoto, Japan), according to the manufacturer's instructions. Fluorescent nucleotide Cy3-dUTP or Cy5-dUTP was incorporated during reverse transcription of the poly(A) ϩ RNA. The probes were purified and concentrated by passing through Centricon-30 microconcetrators (Millipore). The different fluorescence-labeled probes were mixed and applied onto a microarray slide. Hybridization was carried out at 65°C overnight under a humidified condition. The array was washed, centrifuged, and then scanned with a fluorescence laser confocal slide scanner (Scan Array 4000, GSI Lumonics, Tokyo, Japan). Images were analyzed and fluorescence intensities were measured by Quant Array (GSI Lumonics). Genes showing changes in expression by twofold or more in the average of two experiments, where labeling with the fluorescent dyes were switched during the synthesis, were considered as differentially expressed genes.
Anti-Fas and TNF-␣-induced apoptotic response
Hep191 and HepRXR were cultured in the presence of 10 M PNA for 36 h, followed by treating with anti-Fas antibody (CH-11; MBL, Nagoya, Japan) or recombinant human TNF-␣ (Sigma-Aldrich). Anti-Fas antibody and TNF-␣ were used at final concentrations of 100 and 10 ng/ml, respectively. The minimum concentration of cycloheximide (CHX) required for anti-Fas-induced apoptosis was previously determined as a final concentration of 500 ng/ml (Marusawa et al., 1999) . After 14 or 48 h from the start of anti-Fas-or TNF-␣ treatment, respectively, apoptotic cell death was measured by Cell Death Detection ELISAPLUS (Roche Diagnostics) according to the manufacturer's instructions. This assay is based on the specific determination of mononucleosomes and oligonucleosomes in the cytoplasmic fraction of apoptosis-induced cells. AntiFas-induced apoptotic response in Hep191 was also evaluated using the TUNEL procedure using In Situ Cell Death Detection Kit, Fluorescein (Roche Diagnostics). Cells incubated in chamber slides were fixed with 4% paraformaldehyde in PBS, followed by permeabilization with 0.1% Triton X-100 in 0.1% sodium citrate. DNA strand breaks generated during apoptosis were fluorescein-labeled and detected by fluorescence microscopy. Caspase-3 activity in the anti-Fas-treated Hep191 was evaluated by the CaspACETM Assay System (Promega), according to the manufacturer's instructions. Cytosolic proteins were incubated with the colorimetric substrate Ac-DEVD-pNA in the presence or absence of the caspase inhibitor Z-VAD-FMK. Released pNA, p-nitroaniline, from the substrate upon cleavage by caspase-3 activity was monitored by a photometer at 405 nm. Total protein concentration of the cell lysates was determined using the Pierce Micro BCA protein Assay Reagent Kit (Pierce).
Luciferase assay
Human embryonic kidney 293T cells in 24-mm-diameter dishes were transfected with 0.5 g of HCV-core expressing plasmid pCAGC191 or control pCAGGS, 0.2 g of a reporter plasmid containing ICAD promoter either pIPT-2, -3, or -4 (Kawane et al., 1999) , and 0.01 g of pRL-TK (Promega). After 24 h, cells were harvested, and luciferase activities were determined by the Dual-Luciferase Reporter Assay System (Promega) as described previously (Aoki et al., 1998) . The measured firefly luciferase activities were normalized for transfection efficiency using the values of Renilla luciferase activity determined from the same cell extracts.
